You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSR-042

Showing 1 - 25 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Active, not recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jan 31, 2023

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Dostarlimab (TSR-042) (singly)
  • Dostarlimab (TSR-042) and TSR-022 (combination)
  • Washington, District of Columbia
  • +2 more
Feb 22, 2022

Ovarian Tumor Trial in United States (Dostarlimab, Bevacizumab, Niraparib)

Completed
  • Ovarian Neoplasm
  • Birmingham, Alabama
  • +9 more
Feb 20, 2023

Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)

Not yet recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2023

HRD, Cholangiocarcinoma, Metastatic Cancer Trial (Niraparib, Dostarlimab)

Withdrawn
  • HRD
  • +2 more
  • (no location specified)
Jun 23, 2022

Endometrial Cancer, Cancer of the Endometrium Trial in Saint Louis (drug, radiation, procedure)

Recruiting
  • Endometrial Cancer
  • Cancer of the Endometrium
  • TSR-042
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 4, 2022

Sarcoma, Clear Cell Trial in Lyon, Milan, Sevilla (TSR-042)

Recruiting
  • Sarcoma, Clear Cell
  • TSR-042
  • Lyon, France
  • +2 more
Oct 29, 2021

Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

Recruiting
  • Adult Primary Liver Cancer
  • +2 more
  • TSR-022 and TSR-042
  • Honolulu, Hawaii
    University of Hawaii
Sep 22, 2021

Colon Cancer, DMMR Colorectal Cancer Trial (Dostarlimab)

Not yet recruiting
  • Colon Cancer
  • DMMR Colorectal Cancer
  • (no location specified)
Feb 4, 2022

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 26, 2022

Cervical Cancer, Advanced Cancer Trial in Romania, Spain, Turkey (No Further Treatment, TSR-042)

Recruiting
  • Cervical Cancer
  • Advanced Cancer
  • No Further Treatment
  • TSR-042
  • Elche, Alicante, Spain
  • +28 more
Oct 17, 2022

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

Endometrial Cancer Trial in Canada (Niraparib, TSR-042)

Active, not recruiting
  • Endometrial Cancer
  • Calgary, Alberta, Canada
  • +6 more
Nov 18, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +51 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 15, 2022

Ovarian Cancer Trial in Italy (Niraparib, Dostarlimab, Pegylated liposomal doxorubicin)

Recruiting
  • Ovarian Cancer
  • Brescia, Italy
  • +7 more
Aug 24, 2021

Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

Recruiting
  • Lung Small Cell Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Ovarian Carcinosarcoma, Endometrial Carcinosarcoma Trial in France (Niraparib, Niraparib + TSR-042 (Dostarlimab), Chemotherapy

Recruiting
  • Ovarian Carcinosarcoma
  • Endometrial Carcinosarcoma
  • Angers, France
  • +19 more
Feb 23, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +2 more
Apr 13, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Tumors Trial in United States (Niraparib, Pembrolizumab, TSR-042 (Dostarlimab))

Completed
Has Results
  • Neoplasms
  • Whittier, Alaska
  • +15 more
Aug 29, 2022

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)

Recruiting
  • Endometrial Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jul 5, 2022

Ovarian Tumors Trial in Canada, Spain, United States (Niraparib, TSR-042, Bevacizumab)

Recruiting
  • Ovarian Neoplasms
  • Birmingham, Alabama
  • +24 more
Dec 9, 2022